APREPITANT 40 MG CAPSULE

Aprepitant
$40.6600per EA

Strength

40 mg/1

NDC

68001066617

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

APREPITANT

Approval Type

Generic (ANDA)

FDA Application

ANDA207777

On Market Since

12/1/2025

Pharmacological Classes

Cytochrome P450 2C9 Inducers
Cytochrome P450 3A4 Inducers
Cytochrome P450 3A4 Inhibitors
Neurokinin 1 Antagonists
Substance P/Neurokinin-1 Receptor Antagonist

Price History

1W

0.0%

1M

-4.2%

3M

-13.5%

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-13.5%